Literature DB >> 32298194

Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine.

John F Alcorn1, Raghunandan Avula2, Anish B Chakka2, William E Schwarzmann2, Mary Patricia Nowalk3, Chyongchiou Jeng Lin3, Marianna A Ortiz1,4, William T Horne1, Uma R Chandran2, Jennifer P Nagg1, Richard K Zimmerman3, Kelly S Cole4, Krissy K Moehling3, Judith M Martin1.   

Abstract

The human immune response to inactivated influenza vaccine is dynamic and impacted by age and preexisting immunity. Our goal was to identify postvaccination transcriptomic changes in peripheral blood mononuclear cells from children. Blood samples were obtained before and at 3 or 7 days postvaccination with 2016-2017 quadrivalent inactivated influenza vaccine and RNA sequencing was performed. There were 1,466 differentially expressed genes (DEGs) for the Day 0-Day 3 group and 513 DEGs for the Day 0-Day 7 group. Thirty-three genes were common between the two groups. The majority of the transcriptomic changes at Day 3 represented innate inflammation and apoptosis pathways. Day 7 DEGs were characterized by activation of cellular processes, including the regulation of cytoskeleton, junctions, and metabolism, and increased expression of immunoglobulin genes. DEGs at Day 3 were compared between older and younger children revealing increased inflammatory gene expression in the older group. Vaccine history in the year prior to the study was characterized by robust DEGs at Day 3 with decreased phagosome and dendritic cell maturation in those who had been vaccinated in the previous year. PBMC responses to inactivated influenza vaccination in children differed significantly by the timing of sampling, patient age, and vaccine history. These data provide insight into the expected molecular pathways to be temporally altered by influenza vaccination in children.

Entities:  

Keywords:  Influenza; RNA sequencing; immunity; inflammation; pediatrics

Year:  2020        PMID: 32298194      PMCID: PMC7482876          DOI: 10.1080/21645515.2020.1711677

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  28 in total

1.  Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans.

Authors:  Kristine L Bucasas; Luis M Franco; Chad A Shaw; Molly S Bray; Janet M Wells; Diane Niño; Nancy Arden; John M Quarles; Robert B Couch; John W Belmont
Journal:  J Infect Dis       Date:  2011-02-28       Impact factor: 5.226

2.  A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.

Authors:  Wei Zhu; Brandon W Higgs; Chris Morehouse; Katie Streicher; Christopher S Ambrose; Jennifer Woo; George W Kemble; Bahija Jallal; Yihong Yao
Journal:  Vaccine       Date:  2010-02-12       Impact factor: 3.641

3.  Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.

Authors:  Kelly Stefano Cole; Judith M Martin; William T Horne; Chyongchiou J Lin; Mary Patricia Nowalk; John F Alcorn; Richard K Zimmerman
Journal:  Vaccine       Date:  2017-11-11       Impact factor: 3.641

4.  Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Authors:  Raquel G Cao; Nicolas M Suarez; Gerlinde Obermoser; Santiago M C Lopez; Emilio Flano; Sara E Mertz; Randy A Albrecht; Adolfo García-Sastre; Asuncion Mejias; Hui Xu; Huanying Qin; Derek Blankenship; Karolina Palucka; Virginia Pascual; Octavio Ramilo
Journal:  J Infect Dis       Date:  2014-02-04       Impact factor: 5.226

5.  Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

Authors:  Terry Nolan; Jodie McVernon; Maryanne Skeljo; Peter Richmond; Ushma Wadia; Stephen Lambert; Michael Nissen; Helen Marshall; Robert Booy; Leon Heron; Gunter Hartel; Michael Lai; Russell Basser; Charmaine Gittleson; Michael Greenberg
Journal:  JAMA       Date:  2009-12-21       Impact factor: 56.272

6.  Yearly influenza vaccinations: a double-edged sword?

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Guus F Rimmelzwaan
Journal:  Lancet Infect Dis       Date:  2009-10-30       Impact factor: 25.071

7.  Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells.

Authors:  Shanrong Zhao; Wai-Ping Fung-Leung; Anton Bittner; Karen Ngo; Xuejun Liu
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

8.  Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood.

Authors:  Raj Kurupati; Andrew Kossenkov; Larissa Haut; Senthil Kannan; Zhiquan Xiang; Yan Li; Susan Doyle; Qin Liu; Kenneth Schmader; Louise Showe; Hildegund Ertl
Journal:  Oncotarget       Date:  2016-09-27

9.  Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children.

Authors:  Judith M Martin; Raghunandan Avula; Mary Patricia Nowalk; Chyongchiou Jeng Lin; William T Horne; Uma R Chandran; Jennifer P Nagg; Richard K Zimmerman; Kelly S Cole; John F Alcorn
Journal:  Open Forum Infect Dis       Date:  2018-10-24       Impact factor: 3.835

10.  Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Authors:  Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Suzana Sabaiduc; Alireza Eshaghi; James A Dickinson; Kevin Fonseca; Anne-Luise Winter; Jonathan B Gubbay; Mel Krajden; Martin Petric; Hugues Charest; Nathalie Bastien; Trijntje L Kwindt; Salaheddin M Mahmud; Paul Van Caeseele; Yan Li
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more
  3 in total

1.  Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine.

Authors:  Yuwei Zhang; Xingyu Guo; Cunbao Li; Zengqiang Kou; Lanfang Lin; Mingxiao Yao; Bo Pang; Xiaomei Zhang; Qing Duan; Xueying Tian; Yufang Xing; Xiaolin Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

Review 2.  The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.

Authors:  Yorick Janssens; Jasper Joye; Gwenn Waerlop; Frédéric Clement; Geert Leroux-Roels; Isabel Leroux-Roels
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 3.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.